Target intelligence / Profile preview

novel transcript, antisense to AKTIP

Molecular classification: Other, Non-coding RNA, long non-coding RNA, antisense RNA

Overview

Novel transcript, antisense to AKTIP" (ENSG00000302896) is a predicted or provisionally annotated long non-coding RNA located on the strand opposite to the AKTIP gene. As an antisense transcript, it is presumed to overlap or be positioned near the AKTIP locus, but it is not known to encode a protein and is not a validated target for therapeutic modulation. No established biological function, disease role, interacting drugs, or relevance as a biomarker have been reported for this transcript. Its annotation is based on genomic features rather than experimental characterization.

Other names: ENSG00000302896antisense to AKTIP transcript

Beyond the preview

Go deeper on novel transcript, antisense to AKTIP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to AKTIP.

Explore the full profile